Alkermes (ALKS) Other Working Capital Changes (2017 - 2025)
Alkermes' (ALKS) quarterly Other Working Capital Changes came in at -$2.9 million in Q2 2026, down 11.55% year-over-year from -$3.3 million in Q2 2025, and down 4.15% quarter-over-quarter from -$2.8 million in Q1 2026.
Analysis
Alkermes (ALKS) Other Working Capital Changes (2017 - 2025) Analysis & Trends
Alkermes (ALKS) has reported Other Working Capital Changes for 16 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Working Capital Changes fell 11.55% year-over-year to -$2.9 million in Q2 2026; TTM through Jun 2026 was -$10.8 million, a 6.2% decrease from a year earlier, with the FY2025 full-year figure at -$10.3 million, down 1.95% from the prior year.
- Other Working Capital Changes was -$2.9 million for Q2 2026 at Alkermes, down from -$2.8 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.1 million in Q4 2022 and troughed at -$5.1 million in Q3 2022.
- A 5-year average of -$1.3 million and a median of -$1.1 million in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 363.7% in 2022 and jumped 81.94% in 2023, its largest moves.
- Over 5 years, Other Working Capital Changes stood at -$19.8 million in 2022, then jumped by 81.94% to -$3.6 million in 2023, then gained by 29.32% to -$2.5 million in 2024, then decreased by 2.29% to -$2.6 million in 2025, then dropped by 11.64% to -$2.9 million in 2026.
- The last three Other Working Capital Changes figures came in at -$2.9 million (Q2 2026), -$2.8 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -578,000.00 |
| Sep 30, 2025 | -578,000.00 |
| Jun 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | -1.03 Mn |
| Mar 31, 2025 | 359,000.00 |
| Mar 31, 2025 | 359,000.00 |
| Dec 31, 2024 | -1.09 Mn |
| Dec 31, 2024 | -1.09 Mn |
| Sep 30, 2024 | -972,000.00 |
| Sep 30, 2024 | -972,000.00 |
| Jun 30, 2024 | -1.26 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Mar 31, 2024 | -208,000.00 |
| Mar 31, 2024 | -208,000.00 |
| Dec 31, 2023 | -202,000.00 |
| Dec 31, 2023 | -202,000.00 |
| Sep 30, 2023 | -692,000.00 |
| Sep 30, 2023 | -692,000.00 |
| Jun 30, 2023 | -745,000.00 |
| Jun 30, 2023 | -745,000.00 |